SALIX PHARMACEUTICALS LTD·4

Apr 22, 6:18 PM ET

D ALONZO THOMAS 4

4 · SALIX PHARMACEUTICALS LTD · Filed Apr 22, 2013

Insider Transaction Report

Form 4
Period: 2013-04-18
Transactions
  • Award

    Common Stock

    2013-04-18$48.70/sh+4,110$200,15788,564 total
Holdings
  • Common Stock

    (indirect: By Trust)
    1,080
  • Common Stock

    (indirect: By Spouse)
    6,500
  • Common Stock

    (indirect: By LP)
    260
  • Option to Buy Common Stock

    Exercise: $18.87Exp: 2014-06-17Common Stock (22,500 underlying)
    22,500
  • Option to Buy Common Stock

    Exercise: $17.63Exp: 2015-06-09Common Stock (15,000 underlying)
    15,000
Footnotes (3)
  • [F1]Represents a restricted stock award which vests in its entirety on the earlier of July 1, 2014 or immediately prior to the 2014 Annual Stockholder meeting, subject to continued service as a director.
  • [F2]The shares are held by the Rachel L. D'Alonzo Rev Trust U/A DTD 10/24/2001 for which the Reporting Person serves as co-trustee.
  • [F3]Options are 100% vested.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION